Elisa Pierpaoli, et al. “Determination of Antimetastatic and Antitumor Activities of Orally Administered NAX014 Compound in a Murine Model of HER2-Positive Breast Cancer”. Perspective of Recent Advances in Medical Research Vol. 2, Dec. 2022, pp. 109-27, doi:10.9734/bpi/pramr/v2/3905C.